3,4-dihydroxybenzohydroxamic acid has been researched along with Acute Myelogenous Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cook, GJ | 1 |
| Caudell, DL | 1 |
| Elford, HL | 1 |
| Pardee, TS | 1 |
1 other study available for 3,4-dihydroxybenzohydroxamic acid and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
The efficacy of the ribonucleotide reductase inhibitor Didox in preclinical models of AML.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Apoptosis; Disease Models, Animal; D | 2014 |